3-Fluoro-2-[(1-methylpiperidin-4-yl)methoxy]aniline, 95.0%, 1g

5-Bromo-4-chloro-2-fluorobenzoic acid, 95.0%, 5g

2-Chloro-1-(1-(3-fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl)ethanone, 95.0%, 2.5g

2-(1-methyl-1H-benzimidazol-2-yl)ethanol dihydrate, 95.0%, 10g

6-Isopropyl-7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile, 97.0%, 1mg

2-Methoxy-pyrrolidine-1-carboxylic acid methylester, 25g

Ethyl 4-bromo-2-methylbenzoate, 95.0%, 100g

2,6-Di-tert-butyl-4-dimethylaminomethylphenol>98.0%(HPLC)(T)25g

(2E)-1-(2-chlorophenyl)-3-(2,3-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

(2,8-Bis(trifluoromethyl)quinolin-4-yl)(pyridin-2-yl)methanone, 95.0%, 1g

Colonne HPLC NUCLEODUR® C8 Gravité 3 µm, 250 mm, 4,6 mm, 1 pièce(s)

(2,3-dimethoxy-5-methylphenyl)boronic acid, 95.0%, 250mg

4-Ethoxy-benzenesulfonyl chloride, 95.0%, 25g